Narrow Implants Vs Standard Implants With Simultaneous GBR
Narrow Diameter Implants Versus Standard Diameter Implants With Simultaneous Bone Regeneration For The Treatment Of Atrophic Posterior Area
1 other identifier
interventional
30
1 country
1
Brief Summary
NDI represent an advisable treatment option when the mesio-distal space is compromised. In a recent retrospective study with a follow-up of 8 years in which they wanted to evaluate the long-term survival, complications, peri-implant conditions, marginal bone loss, and patient satisfaction of fixed dental prostheses supported by NDI in the posterior area. They observe a survival rate of 97% and absence of prosthetic complications after the study period time. More recently, Souza et al. performed a prospective randomized split mouth study with 3 years follow-up with the aim of comparing marginal bone level, implant survival and success rates and prosthesis success rates of NDI and SDI placed in the posterior area of the mandible to support single prosthesis. They observed an implant survival rate of 100% for both groups at 1 and 3 years. The prosthesis success rate at 1 and 3 years was of 95.4% and 100%, respectively. NDI present a high survival rate on the evaluated studies. Therefore, the aim of the first study is to compare the patient related outcomes, implants and prostheses success and survival rates of pure titanium NDI versus SDI with simultaneous bone regeneration in narrow alveolar ridges at posterior areas of the maxilla and the mandible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2021
CompletedFirst Submitted
Initial submission to the registry
November 15, 2023
CompletedFirst Posted
Study publicly available on registry
December 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2025
CompletedMarch 11, 2026
May 1, 2024
3.5 years
November 15, 2023
March 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Marginal bone level difference
To assess the MBL, each radiograph must register the most coronal aspect of the bone crest (BC) at mesial and distal to the implant, the position of the implant shoulder (IS) and the first bone to implant contact (FBiC). The marginal bone crest level (MBL) will be measured by calculating the distance between BC and IS. MBL will be considered negative when position of BC is coronal to IS, positive when position BC is apical to IS.
The changes in MBL will be registered at 8 weeks, 6 months, 12 months, and 3 years.
Secondary Outcomes (13)
Patient related outcomes
At 1, 2 and 12 weeks
Patient Related Outcomes
At 1, 2 and 12 weeks
Patient Related Outcomes
At 7 days
Patient Related Outcomes
At 7 days
Implant survival criteria:
12 months
- +8 more secondary outcomes
Study Arms (2)
Test Group
EXPERIMENTALControl group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patients:
- years old
- Healthy periodontal status (absence of generalized probing pocket depth (PPD) \<4mm)
- Oral hygiene levels (FMPS \<20 and FMBS \<20)
- Site:
- Ridge width of \>5mm and \<6.5mm and minimum bone height of 10mm prior evaluation on a CBCT scan
- Presence of antagonistic natural tooth or fixed prosthetic restoration
- Presence of adjacent teeth
- One maxillary or mandibular premolars
- Minimum of 3mm of keratinized tissue over the bone crest (20)
- Bone regeneration within the limits of the prosthetic restoration.
- Implants:
- Unitary prosthesis
- Screwed retained restorations
You may not qualify if:
- Patients
- Presence of active chronic or aggressive periodontal disease
- Presence of systemic disease which contraindicate surgery (patients with an ASA ≥ 3)
- Drugs or medications which may alter the results (chronic intake of analgesic medication)
- Smokers (\>10cig/day)
- Pregnant women
- History of head and neck radiotherapy.
- Site
- Anterior area (from 1.3 to 2.3 and from 3.3 to 4.3) and molar area
- Previous guided bone regeneration
- Location where there is not sufficient restorative space (mesio-distally \<8mm for every restoration unit and \<5mm from the bone crest to the antagonist)
- Implant dehiscence of more than 2/3 of the implant.
- Implant
- Implants which cannot be restored with a screwed restoration
- Implants which doesn't reach a manual implant stability
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitat Internacional de Catalunya
Sant Cugat del Vallès, Barcelona, 08195, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor Dental Surgery
Study Record Dates
First Submitted
November 15, 2023
First Posted
December 13, 2023
Study Start
July 12, 2021
Primary Completion
December 28, 2024
Study Completion
December 28, 2025
Last Updated
March 11, 2026
Record last verified: 2024-05